Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: Clinical and epidemiological implications

Clinical Microbiology and Infection

Volumn 13, Issue 10, 2007, Pages 1026-1029

  Pena C ^a   Suarez, C ^a   Tubau, F ^a   Gutierrez, O ^b   Dominguez A ^a   Oliver, A ^b   Pujol, M ^a   Gudiol, F ^a   Ariza, J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Microbiology Service   (Spain)

Author keywords

Epidemiology; Metallo lactamase; Pan resistance; Pseudomonas aeruginosa; Surveillance; VIM 2

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEPHALOSPORIN DERIVATIVE; COLISTIN; EDETIC ACID; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; METALLO BETA LACTAMASE VIM 2; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CLINICAL ARTICLE; DISEASE SURVEILLANCE; ENDEMIC DISEASE; ENZYME SYNTHESIS; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SPAIN; SURGICAL WARD; UNIVERSITY HOSPITAL;

PSEUDOMONAS AERUGINOSA;

EID: 34548531286     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01784.x     Document Type: Article

References (20)

1. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35: 147-151.
2. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8: 321-331.
3. Prats G, Miro I, Mirelis B, Poirel L, Bellais S, Nordmann P. First isolation of a carbapenem-hydrolyzing β-lactamase in Pseudomonas aeruginosa in Spain. Antimicrob Agents Chemother 2002; 46: 932-933.
4. Paterson DL. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species. Clin Infect Dis 2006; 43 (suppl 2): S43-S48.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement, document M100-S16. Wayne, PA: CLSI, 2006.
6. Lee K, Sim YS, Yong D et al. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41: 4623-4629.
7. Walsh TR, Bolmstrom A, Qwarnstrom A, Gales A. Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J Clin Microbiol 2002; 40: 2755-2759.
8. Senda K, Arakawa Y, Nakashima K et al. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob Agents Chemother 1996; 40: 349-353.
9. Lauretti L, Riccio ML, Mazzariol A et al. Cloning and characterization of bla VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999; 43: 1584-1590.
10. Poirel L, Naas T, Nicolas D et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000; 44: 891-897.
11. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.
12. Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R. Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-β-lactamase. Clin Infect Dis 2000; 31: 1119-1125.
13. Rossolini GM, Riccio ML, Cornaglia G et al. Carbapenem-resistant Pseudomonas aeruginosa with acquired bla VIM metallo-β-lactamase determinants, Italy. Emerg Infect Dis 2000; 6: 312-313.
14. Cardoso O, Leitao R, Figuereido A, Sousa JC, Duarte A, Peixe L. Metallo-beta-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal. Microb Drug Resist 2002; 8: 93-97.
15. Pournaras S, Maniati M, Petinaki E et al. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4. J Antimicrob Chemother 2003; 51: 1409-1414.
16. Aubron C, Poirel L, Fortineau N, Nicolas P, Collet L, Nordmann P. Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo-β-lactamase VIM-2 in a hematology unit of a French hospital. Microb Drug Resist 2005; 11: 254-259.
17. Henrichfreise B, Wiegand I, Sherwood KJ, Wiedemann B. Detection of VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Germany. Antimicrob Agents Chemother 2005; 49: 1668-1669.
18. Deplano A, Rodriguez-Villalobos H, Glupczynski Y et al. Emergence and dissemination of multidrug resistant clones of Pseudomonas aeruginosa producing VIM-2 metallo-beta-lactamase in Belgium. Euro Surveill 2007; 12: E070118.2.
19. Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States. Antimicrob Agents Chemother 2005; 49: 3538-3540.
20. Nouér SA, Nucci M, de-Oliveira MP, Piffano FL, Meurer B. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. Antimicrob Agents Chemother 2005; 49: 3663-3667.